Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Delivery systems for molecular vaccination.

N A Sheikh¹, M al-Shamisi, W J Morrow

¹Department of Pharmaceutics & Washington Regional Primate Research Center, University of Washington, Seattle, WA 98121, USA.

Current Opinion in Molecular Therapeutics

|March 16, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

No effect of salmon fish protein on 2-h glucose in adults with increased risk of type 2 diabetes: a randomised controlled trial.

The British journal of nutrition·2021

Same author

Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model.

Diagnostic and interventional imaging·2020

Same author

Evaluation of iron chelating and antioxidant potential of Epilobium hirsutum for the management of iron overload disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2017

Same author

Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model.

Drug research·2016

Same author

Life span of MRL/lpr/lpr mice.

Immunology today·2014

Same author

Dietary regulation of the autoimmune process in murine lupus.

Immunology today·2014

Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011

Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010

Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010

Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010

Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010

Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010

See all related articles

Developing effective vaccines, especially for intracellular pathogens, is challenging. This review explores advancements in antigen delivery systems to improve vaccine-induced immune responses and overcome current limitations.

Area of Science:

Immunology
Vaccinology
Biotechnology

Background:

Vaccination is a major public health achievement, yet prophylactic regimes are unavailable for many diseases.
Inducing robust immune responses, particularly cell-mediated immunity against intracellular pathogens, remains a significant hurdle in vaccine development.
Recombinant soluble protein subunits often fail to elicit protective immunity due to poor access to antigen-processing pathways.

Purpose of the Study:

To review key developments in antigen delivery systems for vaccination.
To highlight how delivery systems influence the quality and quantity of immune responses.
To address the challenge of inducing cell-mediated immunity for vaccines against intracellular pathogens.

Main Methods:

Review of recent scientific literature on antigen delivery systems.

Related Experiment Videos

Analysis of mechanisms underlying antigen processing and immune response induction.

Discussion of the impact of various delivery platforms on vaccine efficacy.

Main Results:

Significant progress has been made in understanding antigen processing and delivery.
Delivery systems can be engineered to enhance antigen presentation and immune stimulation.
New strategies are emerging to elicit cell-mediated immunity crucial for fighting intracellular pathogens.

Conclusions:

Advances in antigen delivery systems offer promising solutions for developing effective vaccines against challenging diseases.
Optimizing antigen delivery is critical for overcoming current limitations in vaccine-induced immunity.
Further research in this area holds potential for future mass immunization programs.